Tourmaline Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $45,409,000.

Profit Margin

Tourmaline Bio, Inc. (NASDAQ:TRML): Profit margin
2020 0 -22.70M
2023 0 -42.12M

TRML Income Statement (2020 – 2023)

2023 2020
Revenue
Revenue
00
Cost of revenue
33K447K
Gross profit
-33K-447K
Operating exp.
Research and development
32.36M15.27M
Selling and marketing
00
Total operating expenses
45.40M22.23M
Operating income
-45.40M-22.68M
Other income (expenses), net
3.28M-23K
Income before tax
-42.12M-22.70M
Income tax expense
00
Net income
-42.12M-22.70M
Earnings per share
Basic EPS
-8.87-33.97
Diluted EPS
-8.87-33.97
Data source